Clinical Trial

Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A clinical human dietary intervention trial was conducted to investigate the effects of GLP-1 FORMUL liquid supplementation in individuals with prediabetes or obesity, with a focus on improvements in glycemic and lipid parameters, body composition, and gut microbiota profiles.
Trial Details
NCT Number NCT07089732
Lead Sponsor Chung Shan Medical University
Conditions Obesity, Prediabetes
Enrollment 100 participants
Start Date 2025-08-08
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-28